SCHEMBL429826

SCHEMBL429826

CCCCN(CCCC)CCC[O]

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 2/20 0.42
CA1 P00915 2/20 0.42
CA9 Q16790 2/20 0.42
KDM5A P29375 4/20 0.39
PHF8 Q9UPP1 2/20 0.37
KDM4C Q9H3R0 2/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
MAPT P10636 1/20 0.35
MMP1 P03956 1/20 0.34
MMP2 P08253 1/20 0.34
MMP3 P08254 1/20 0.34
MMP8 P22894 1/20 0.34
LMNA P02545 2/20 0.34
THRA P10827 2/20 0.34
THRB P10828 2/20 0.34
CYP1A2 P05177 1/20 0.34
CHRM2 P08172 1/20 0.34
CYP3A4 P08684 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7297600 0.92 KDM5A (0.42) CA12CA1CA9KDM5APHF8
SCHEMBL4394110 0.89 DNM1 (0.48) CA12CA1CA9KDM5APHF8
SCHEMBL5243912 0.88 CA12 (0.35) CA12CA1CA9KDM5AHTR1A
SCHEMBL4393301 0.88 CA12 (0.42) CA12CA1CA9KDM5APHF8
Iodomethane SCHEMBL8377899 0.84 CA12 (0.42) CA12CA1CA9KDM5APHF8
SCHEMBL27566038 0.84 TSHR (0.46) CA12CA1CA9KDM5APHF8
SCHEMBL3904839 0.84 TSHR (0.46) CA12CA1CA9KDM5APHF8
SCHEMBL896 0.84 TSHR (0.46) CA12CA1CA9KDM5APHF8
SCHEMBL7927964 0.83 CA12 (0.39) CA12CA1CA9KDM5APHF8
SCHEMBL8053577 0.83 DNM1 (0.48) CA12CA1CA9KDM5APHF8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9499507-B2 Method for preparing 5-amino-benzoyl-benzofuran derivatives SANOFI (FR) 2016-11-22 US claimed
US-20150031901-A1 METHOD FOR PREPARING 5-AMINO-BENZOFURAN DERIVATIVES SANOFI (FR) 2015-01-29 US claimed
US-8884033-B2 Process for preparing aminobenzoylbenzofuran derivatives SANOFI (FR) 2014-11-11 US claimed
US-8748636-B2 Process for preparing benzofuran derivatives substituted at position 5 SANOFI (FR) 2014-06-10 US claimed
US-20130165674-A1 PROCESS FOR PREPARING BENZOFURAN DERIVATIVES SUBSTITUTED AT POSITION 5 SANOFI (FR) 2013-06-27 US claimed
US-20130165675-A1 PROCESS FOR PREPARING AMINOBENZOYLBENZOFURAN DERIVATIVES SANOFI (FR) 2013-06-27 US claimed
WO-2013079866-A1 METHOD FOR PREPARING 5-AMINO-BENZOYL-BENZOFURAN DERIVATIVES SANOFI (FR) 2013-06-06 WO claimed
EP-2595977-A1 PROCESS FOR PREPARING BENZOFURAN DERIVATIVES SUBSTITUTED AT POSITION 5 SANOFI (FR) 2013-05-29 EP claimed
EP-2595976-A1 PROCESS FOR PREPARING AMINOBENZOYLBENZOFURAN DERIVATIVES SANOFI (FR) 2013-05-29 EP claimed
WO-2012010788-A1 PROCESS FOR PREPARING AMINOBENZOYLBENZOFURAN DERIVATIVES SANOFI (FR) 2012-01-26 WO claimed
WO-2012010802-A1 PROCESS FOR PREPARING BENZOFURAN DERIVATIVES SUBSTITUTED AT POSITION 5 SANOFI (FR) 2012-01-26 WO claimed
US-9499507-B2 Method for preparing 5-amino-benzoyl-benzofuran derivatives SANOFI (FR) 2016-11-22 US disclosed
US-20150031901-A1 METHOD FOR PREPARING 5-AMINO-BENZOFURAN DERIVATIVES SANOFI (FR) 2015-01-29 US disclosed
US-8884033-B2 Process for preparing aminobenzoylbenzofuran derivatives SANOFI (FR) 2014-11-11 US disclosed
US-8748636-B2 Process for preparing benzofuran derivatives substituted at position 5 SANOFI (FR) 2014-06-10 US disclosed
EP-0818512-A1 Quinoline derivative and use of same MITSUI TOATSU CHEMICALS, Inc. (JP) 1998-01-14 EP disclosed
US-4562211-A ANTIDEPRESSANTS MITSUBISHI CHEMICAL INDUSTRIES, LTD. (JP) 1985-12-31 US disclosed
US-4091114-A ANTIDEPRESSANTS MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JA) 1978-05-23 US disclosed
US-4060641-A ANTIDEPRESSANT MITSUBISHI CHEMICAL INDUSTRIES LTD. (JA) 1977-11-29 US disclosed
US-4024282-A Pharmaceutically active 2-(3-alkylaminopropoxy)diphenylmethanes MITSUBISHI CHEMICAL INDUSTRIES LTD. (JA) 1977-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130165675-A1 PROCESS FOR PREPARING AMINOBENZOYLBENZOFURAN DERIVATIVES ALKBH5, ALKBH1, PRMT5 CA12 3136/4885CA1 4233/4885CA9 2788/4885
US-20130165674-A1 PROCESS FOR PREPARING BENZOFURAN DERIVATIVES SUBSTITUTED AT POSITION 5 DHPS, SDHA, CYP2F1 CA12 3351/4885CA1 3298/4885CA9 3448/4885
US-20150031901-A1 METHOD FOR PREPARING 5-AMINO-BENZOFURAN DERIVATIVES ALKBH5, CYP3A5, ALKBH1 CA12 4767/4885CA1 4817/4885CA9 4065/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.